Glucagon-like peptide-1 (GLP-1) drugs help people lose weight by making them feel fuller with less food and by signaling the brain that the stomach contains food, reducing their appetite and cravings
In comparison, Ipamorelin increases body fat, especially at the start of the therapy
In its pivotal trial, 62% of patients treated with Saxenda lost at least 5% of their body weight compared with 34% of patients treated with placebo
Serotonin synthesis genes were unaffected in the colon of PAS * -treated mice, which suggests that PAS * does not regulate the serotonin pathway during colitis [62]
The liver fat reduction is already substantial at this dose level, with 79% of MASLD trial participants achieving normal liver fat at 8mg
In some embodiments, the otoprotectant is a compound comprising a urea-thiophene-carboxamide moiety of Formula (III): wherein X is a heteroatom that includes N, O, or S